788 reports of this reaction
11.9% of all OMEPRAZOLE AND SODIUM BICARBONATE reports
#1 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #1 most commonly reported adverse reaction for OMEPRAZOLE AND SODIUM BICARBONATE, manufactured by Santarus, Inc... There are 788 FDA adverse event reports linking OMEPRAZOLE AND SODIUM BICARBONATE to CHRONIC KIDNEY DISEASE. This represents approximately 11.9% of all 6,647 adverse event reports for this drug.
Patients taking OMEPRAZOLE AND SODIUM BICARBONATE who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is a frequently reported adverse event for OMEPRAZOLE AND SODIUM BICARBONATE, accounting for a significant proportion of all reports.
In addition to chronic kidney disease, the following adverse reactions have been reported for OMEPRAZOLE AND SODIUM BICARBONATE:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 788 FDA reports for OMEPRAZOLE AND SODIUM BICARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 11.9% of all adverse event reports for OMEPRAZOLE AND SODIUM BICARBONATE, making it one of the most commonly reported side effect.
If you experience chronic kidney disease while taking OMEPRAZOLE AND SODIUM BICARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.